Trial Profile
The Effect of Weight Loss With Orlistat or Sibutramine Administration, Hypocaloric Diet and Physical Exercise, on AMH Levels, in Women With Polycystic Ovary Syndrome
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Orlistat (Primary) ; Sibutramine (Primary)
- Indications Obesity; Polycystic ovary syndrome
- Focus Pharmacodynamics
- 23 Nov 2011 New trial record